Nimesulide and hepatic adverse effects: Roles of reactive metabolites and host factors

International Journal of Clinical Practice, Supplement

Volumn , Issue 128, 2002, Pages 30-36

  Boelsterli, U A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Hepatotoxicity; Idiosyncratic drug reactions; Nimesulide; Nitro aromatic compounds; NSAIDs

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; NIMESULIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

CONFERENCE PAPER; DRUG ACTIVATION; DRUG METABOLISM; HUMAN; INCIDENCE; LIVER INJURY; LIVER MITOCHONDRION; LIVER TOXICITY; MEMBRANE PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; TOXICOKINETICS; BIOTRANSFORMATION; DRUG EFFECT; ENZYMOLOGY; LIVER; METABOLISM; NECROSIS; PATHOLOGY; POSTMARKETING SURVEILLANCE; REVIEW; TIME;

BIOTRANSFORMATION; CYCLOOXYGENASE INHIBITORS; HUMANS; INCIDENCE; LIVER; MITOCHONDRIA, LIVER; NECROSIS; PRODUCT SURVEILLANCE, POSTMARKETING; SULFONAMIDES; TIME FACTORS;

EID: 0035984660     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Mechanisms underlying the hepatotoxicity of nonsteroidal anti-inflammatory drugs
2. An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injury
3. Value of epidemiologic studies in determining the true incidence of adverse events. The nonsteroidal anti-inflammatory drug story
4. Hepatitis-like syndrome induced by nimesulide?
5. Hepatotoxicity associated with nimesulide
6. Nimesulide-induced acute hepatitis: Evidence from six cases
7. COX 2 inhibitor and fulminant hepatic failure
8. Acute cholestatic hepatitis induced by nimesulide
9. Nimesulide-induced hepatitis and acute liver failure
10. Fatal hepatitis associated with nimesulide
11. Fatal hepatitis and renal failure during treatment with nimesulide
12. Fatal hepatotoxicity secondary to nimesulide
13. Drug-induced liver disorders. Implications for drug development and regulation
14. Idiosyncratic liver toxicity of nonsteroidal anti-inflammatory drugs: Molecular mechanisms and pathology
15. Detection and incidence of drug-induced liver injuries in hospital: A prospective analysis from laboratory signals
16. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs
17. Drug hepatotoxicity
18. 4-Nitro-2-phenoxymethane sulfoanilide (R-805): A chemically novel antiinflammatory agent
19. Nonsteroidal anti-inflammatories-XII. Mode of action of anti-inflammatory methane sulfonanilides
20. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione - Implications for idiosyncratic toxicity
21. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection
22. Electrochemical generation and interaction study of the nitro anion from nimesulide
23. Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs
24. Effects of nimesulide and its reduced metabolite on mitochondria
25. The uncoupling effect of the nonsteroidal anti-inflammatory drug nimesulide in liver mitochondria from adjuvant-induced arthritic rats
26. Clinical pharmacokinetics of nimesulide